{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T22:39:03Z","timestamp":1792795143731,"version":"4.5.0"},"reference-count":95,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T00:00:00Z","timestamp":1767052800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T00:00:00Z","timestamp":1769731200000},"content-version":"vor","delay-in-days":31,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Microb Cell Fact"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Bacterial membrane vesicles (BMVs) are nanoscale, bilayered proteolipid structures secreted by both Gram-negative and Gram-positive bacteria. Initially considered cellular debris, BMVs are now recognized as evolutionarily conserved entities with critical roles in bacterial communication, immune modulation, virulence factor delivery, and horizontal gene transfer. Their structural and functional resemblance to eukaryotic extracellular vesicles has fueled growing interest in their use as versatile vaccine platforms. Licensed meningococcal OMV vaccines established proof-of-concept for their safety and immunogenicity, and ongoing studies are extending applications to enteric pathogens and viral infections. Recent advances in genetic engineering, glycoengineering, and modular antigen display systems have enabled the design of \u201cplug-and-play\u201d BMVs with reduced reactogenicity and enhanced protective efficacy. In parallel, innovations in bioprocessing and formulation technologies are improving scalability, stability, and delivery, including mucosal routes. This review highlights the immunological properties, translational potential, and key challenges of BMV-based vaccines, with an emphasis on strategies to optimize safety, antigen specificity, and manufacturing for next-generation vaccine development.<\/jats:p>","DOI":"10.1186\/s12934-025-02908-5","type":"journal-article","created":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T20:34:59Z","timestamp":1767126899000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Tiny packages, big potential: bacterial membrane vesicles in vaccinology"],"prefix":"10.1186","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2880-4321","authenticated-orcid":false,"given":"Ay\u015fe","family":"Varol","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-5640-3363","authenticated-orcid":false,"given":"\u015eeyma","family":"Ayd\u0131n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8848-6647","authenticated-orcid":false,"given":"Ahmet","family":"Ad\u0131g\u00fczel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7539-0523","authenticated-orcid":false,"given":"Sel\u00e7uk","family":"\u00d6zdemir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,30]]},"reference":[{"key":"2908_CR1","doi-asserted-by":"publisher","unstructured":"Fadeev E, Carpaneto Bastos C, Hennenfeind JH, Biller SJ, Sher D, Wietz M, et al. Characterization of membrane vesicles in Alteromonas Macleodii indicates potential roles in their copiotrophic lifestyle. MicroLife. 2023;4. https:\/\/doi.org\/10.1093\/femsml\/uqac025.","DOI":"10.1093\/femsml\/uqac025"},{"key":"2908_CR2","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.actbio.2024.02.029","volume":"178","author":"G-J Jeong","year":"2024","unstructured":"Jeong G-J, Khan F, Tabassum N, Cho K-J, Kim Y-M. Bacterial extracellular vesicles: modulation of biofilm and virulence properties. Acta Biomater. 2024;178:13\u201323. https:\/\/doi.org\/10.1016\/j.actbio.2024.02.029.","journal-title":"Acta Biomater"},{"key":"2908_CR3","doi-asserted-by":"publisher","unstructured":"Toyofuku M, Nomura N, Eberl L. Types and origins of bacterial membrane vesicles. Nat Rev Microbiol. 2019;13\u201324. https:\/\/doi.org\/10.1038\/s41579-018-0112-2.","DOI":"10.1038\/s41579-018-0112-2"},{"key":"2908_CR4","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.cis.2015.08.013","volume":"226","author":"M Toyofuku","year":"2015","unstructured":"Toyofuku M, Tashiro Y, Hasegawa Y, Kurosawa M, Nomura N. Bacterial membrane vesicles, an overlooked environmental colloid: Biology, environmental perspectives and applications. Adv Colloid Interface Sci. 2015;226:65\u201377. https:\/\/doi.org\/10.1016\/j.cis.2015.08.013.","journal-title":"Adv Colloid Interface Sci"},{"key":"2908_CR5","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1111\/j.1462-2920.2006.01043.x","volume":"8","author":"M Nevot","year":"2006","unstructured":"Nevot M, Deroncel\u00e9 V, Messner P, Guinea J, Mercad\u00e9 E. Characterization of outer membrane vesicles released by the psychrotolerant bacterium Pseudoalteromonas Antarctica NF 3. Environ Microbiol. 2006;8:1523\u201333. https:\/\/doi.org\/10.1111\/j.1462-2920.2006.01043.x.","journal-title":"Environ Microbiol"},{"key":"2908_CR6","doi-asserted-by":"publisher","first-page":"3998","DOI":"10.1128\/jb.177.14.3998-4008.1995","volume":"177","author":"JL Kadurugamuwa","year":"1995","unstructured":"Kadurugamuwa JL, Beveridge TJ. Virulence factors are released from Pseudomonas aeruginosa in association with membrane vesicles during normal growth and exposure to gentamicin: a novel mechanism of enzyme secretion. J Bacteriol. 1995;177:3998\u20134008. https:\/\/doi.org\/10.1128\/jb.177.14.3998-4008.1995.","journal-title":"J Bacteriol"},{"key":"2908_CR7","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.1128\/AEM.65.5.1843-1848.1999","volume":"65","author":"GL Kolling","year":"1999","unstructured":"Kolling GL, Matthews KR. Export of virulence genes and Shiga toxin by membrane vesicles of Escherichia coli O157:H7. Appl Environ Microbiol. 1999;65:1843\u20138. https:\/\/doi.org\/10.1128\/AEM.65.5.1843-1848.1999.","journal-title":"Appl Environ Microbiol"},{"key":"2908_CR8","doi-asserted-by":"publisher","unstructured":"Wang S, Gao J, Wang Z. Outer membrane vesicles for vaccination and targeted drug delivery. WIREs Nanomed Nanobiotechnol. 2019;11. https:\/\/doi.org\/10.1002\/wnan.1523.","DOI":"10.1002\/wnan.1523"},{"key":"2908_CR9","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1146\/annurev.micro.091208.073413","volume":"64","author":"A Kulp","year":"2010","unstructured":"Kulp A, Kuehn MJ. Biological functions and biogenesis of secreted bacterial outer membrane vesicles. Annu Rev Microbiol. 2010;64:163\u201384. https:\/\/doi.org\/10.1146\/annurev.micro.091208.073413.","journal-title":"Annu Rev Microbiol"},{"key":"2908_CR10","doi-asserted-by":"publisher","first-page":"5985","DOI":"10.3390\/ijms22115985","volume":"22","author":"F Dell\u2019Annunziata","year":"2021","unstructured":"Dell\u2019Annunziata F, Folliero V, Giugliano R, De Filippis A, Santarcangelo C, Izzo V, et al. Gene transfer potential of outer membrane vesicles of Gram-Negative bacteria. Int J Mol Sci. 2021;22:5985. https:\/\/doi.org\/10.3390\/ijms22115985.","journal-title":"Int J Mol Sci"},{"key":"2908_CR11","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1093\/femsre\/fuz009","volume":"43","author":"S Ronneau","year":"2019","unstructured":"Ronneau S, Hallez R. Make and break the alarmone: regulation of (p)ppGpp synthetase\/hydrolase enzymes in bacteria. FEMS Microbiol Rev. 2019;43:389\u2013400. https:\/\/doi.org\/10.1093\/femsre\/fuz009.","journal-title":"FEMS Microbiol Rev"},{"key":"2908_CR12","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1002\/mas.20175","volume":"27","author":"E Lee","year":"2008","unstructured":"Lee E, Choi D, Kim K, Gho YS. Proteomics in gram-negative bacterial outer membrane vesicles. Mass Spectrom Rev. 2008;27:535\u201355. https:\/\/doi.org\/10.1002\/mas.20175.","journal-title":"Mass Spectrom Rev"},{"key":"2908_CR13","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1111\/cmi.12658","volume":"18","author":"RD Pathirana","year":"2016","unstructured":"Pathirana RD, Kaparakis-Liaskos M. Bacterial membrane vesicles: Biogenesis, immune regulation and pathogenesis. Cell Microbiol. 2016;18:1518\u201324. https:\/\/doi.org\/10.1111\/cmi.12658.","journal-title":"Cell Microbiol"},{"key":"2908_CR14","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1515\/hsz-2014-0183","volume":"396","author":"MF Haurat","year":"2015","unstructured":"Haurat MF, Elhenawy W, Feldman MF. Prokaryotic membrane vesicles: new insights on biogenesis and biological roles. Biol Chem. 2015;396:95\u2013109. https:\/\/doi.org\/10.1515\/hsz-2014-0183.","journal-title":"Biol Chem"},{"key":"2908_CR15","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1007\/s00253-021-11140-1","volume":"105","author":"Y Cao","year":"2021","unstructured":"Cao Y, Lin H. Characterization and function of membrane vesicles in Gram-positive bacteria. Appl Microbiol Biotechnol. 2021;105:1795\u2013801. https:\/\/doi.org\/10.1007\/s00253-021-11140-1.","journal-title":"Appl Microbiol Biotechnol"},{"key":"2908_CR16","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.bbapap.2012.09.015","volume":"1834","author":"C Chowdhury","year":"2013","unstructured":"Chowdhury C, Jagannadham MV. Virulence factors are released in association with outer membrane vesicles of Pseudomonas syringae pv. tomato T1 during normal growth. Biochim Et Biophys Acta (BBA) - Proteins Proteom. 2013;1834:231\u20139. https:\/\/doi.org\/10.1016\/j.bbapap.2012.09.015.","journal-title":"Biochim Et Biophys Acta (BBA) - Proteins Proteom"},{"key":"2908_CR17","doi-asserted-by":"publisher","first-page":"12489","DOI":"10.1074\/jbc.275.17.12489","volume":"275","author":"AL Horstman","year":"2000","unstructured":"Horstman AL, Kuehn MJ. Enterotoxigenic Escherichia coli secretes active Heat-labile enterotoxin via outer membrane vesicles. J Biol Chem. 2000;275:12489\u201396. https:\/\/doi.org\/10.1074\/jbc.275.17.12489.","journal-title":"J Biol Chem"},{"key":"2908_CR18","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.3390\/pharmaceutics13111887","volume":"13","author":"A Naskar","year":"2021","unstructured":"Naskar A, Cho H, Lee S, Kim K. Biomimetic nanoparticles coated with bacterial outer membrane vesicles as a New-Generation platform for biomedical applications. Pharmaceutics. 2021;13:1887. https:\/\/doi.org\/10.3390\/pharmaceutics13111887.","journal-title":"Pharmaceutics"},{"key":"2908_CR19","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1002\/biot.201400395","volume":"10","author":"L van der Pol","year":"2015","unstructured":"van der Pol L, Stork M, van der Ley P. Outer membrane vesicles as platform vaccine technology. Biotechnol J. 2015;10:1689\u2013706. https:\/\/doi.org\/10.1002\/biot.201400395.","journal-title":"Biotechnol J"},{"key":"2908_CR20","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.semcdb.2015.02.006","volume":"40","author":"JH Kim","year":"2015","unstructured":"Kim JH, Lee J, Park J, Gho YS. Gram-negative and Gram-positive bacterial extracellular vesicles. Semin Cell Dev Biol. 2015;40:97\u2013104. https:\/\/doi.org\/10.1016\/j.semcdb.2015.02.006.","journal-title":"Semin Cell Dev Biol"},{"key":"2908_CR21","doi-asserted-by":"publisher","unstructured":"Bitto NJ, Chapman R, Pidot S, Costin A, Lo C, Choi J, et al. Bacterial membrane vesicles transport their DNA cargo into host cells. Sci Rep. 2017;7. https:\/\/doi.org\/10.1038\/s41598-017-07288-4.","DOI":"10.1038\/s41598-017-07288-4"},{"key":"2908_CR22","doi-asserted-by":"publisher","first-page":"860","DOI":"10.3390\/membranes13110860","volume":"13","author":"B Marinacci","year":"2023","unstructured":"Marinacci B, Krzy\u017cek P, Pellegrini B, Turacchio G, Grande R. Latest update on outer membrane vesicles and their role in horizontal gene transfer: A Mini-Review. Membr (Basel). 2023;13:860. https:\/\/doi.org\/10.3390\/membranes13110860.","journal-title":"Membr (Basel)"},{"key":"2908_CR23","doi-asserted-by":"publisher","unstructured":"Li P, Luo W, Xiang T-X, Jiang Y, Liu P, Wei D-D, et al. Horizontal gene transfer via OMVs co-carrying virulence and antimicrobial-resistant genes is a novel way for the dissemination of carbapenem-resistant hypervirulent Klebsiella pneumoniae. Front Microbiol. 2022;13. https:\/\/doi.org\/10.3389\/fmicb.2022.945972.","DOI":"10.3389\/fmicb.2022.945972"},{"key":"2908_CR24","doi-asserted-by":"publisher","first-page":"2904","DOI":"10.3390\/ijms25052904","volume":"25","author":"G Sangiorgio","year":"2024","unstructured":"Sangiorgio G, Nicitra E, Bivona D, Bonomo C, Bonacci P, Santagati M, et al. Interactions of Gram-Positive bacterial membrane vesicles and hosts: updates and future directions. Int J Mol Sci. 2024;25:2904. https:\/\/doi.org\/10.3390\/ijms25052904.","journal-title":"Int J Mol Sci"},{"key":"2908_CR25","doi-asserted-by":"publisher","first-page":"670","DOI":"10.3390\/microorganisms8050670","volume":"8","author":"MJ Uddin","year":"2020","unstructured":"Uddin MJ, Dawan J, Jeon G, Yu T, He X, Ahn J. The role of bacterial membrane vesicles in the dissemination of antibiotic resistance and as promising carriers for therapeutic agent delivery. Microorganisms. 2020;8:670. https:\/\/doi.org\/10.3390\/microorganisms8050670.","journal-title":"Microorganisms"},{"key":"2908_CR26","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/978-1-4899-3564-9_10","volume-title":"Analytical microbiology methods","author":"B Lindner","year":"1990","unstructured":"Lindner B, Zahringer U, Rietschel ETh, Seydel U. Structural Elucidation of lipopolysaccharides and their lipid a component: application of soft ionization mass spectrometry. Analytical microbiology methods. Boston, MA: Springer US; 1990. pp. 149\u201361. https:\/\/doi.org\/10.1007\/978-1-4899-3564-9_10."},{"key":"2908_CR27","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.chom.2013.06.006","volume":"14","author":"Y Handa","year":"2013","unstructured":"Handa Y, Durkin CH, Dodding MP, Way M. Vaccinia virus F11 promotes viral spread by acting as a PDZ-containing scaffolding protein to bind myosin-9A and inhibit RhoA signaling. Cell Host Microbe Cell Press. 2013;14:51\u201362. https:\/\/doi.org\/10.1016\/j.chom.2013.06.006.","journal-title":"Cell Host Microbe Cell Press"},{"key":"2908_CR28","doi-asserted-by":"publisher","first-page":"2431","DOI":"10.1016\/j.carres.2003.07.010","volume":"338","author":"M Caroff","year":"2003","unstructured":"Caroff M, Karibian D. Structure of bacterial lipopolysaccharides. Carbohydr Res. 2003;338:2431\u201347. https:\/\/doi.org\/10.1016\/j.carres.2003.07.010.","journal-title":"Carbohydr Res"},{"key":"2908_CR29","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1128\/IAI.05836-11","volume":"80","author":"A Toledo","year":"2012","unstructured":"Toledo A, Coleman JL, Kuhlow CJ, Crowley JT, Benach JL. The enolase of borrelia burgdorferi is a plasminogen receptor released in outer membrane vesicles. Infect Immun. 2012;80:359\u201368. https:\/\/doi.org\/10.1128\/IAI.05836-11.","journal-title":"Infect Immun"},{"key":"2908_CR30","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1146\/annurev-micro-052821-031444","volume":"75","author":"MG Sartorio","year":"2021","unstructured":"Sartorio MG, Pardue EJ, Feldman MF, Haurat MF. Bacterial outer membrane vesicles: from discovery to applications. Annu Rev Microbiol. 2021;75:609\u201330. https:\/\/doi.org\/10.1146\/annurev-micro-052821-031444.","journal-title":"Annu Rev Microbiol"},{"key":"2908_CR31","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.3390\/vaccines10101578","volume":"10","author":"D Kashyap","year":"2022","unstructured":"Kashyap D, Panda M, Baral B, Varshney N, Bhandari RS. Outer membrane vesicles: an emerging vaccine platform. Vaccines (Basel). 2022;10:1578. https:\/\/doi.org\/10.3390\/vaccines10101578.","journal-title":"Vaccines (Basel)"},{"key":"2908_CR32","doi-asserted-by":"publisher","unstructured":"Cheng K, Zhao R, Li Y, Qi Y, Wang Y, Zhang Y, et al. Bioengineered bacteria-derived outer membrane vesicles as a versatile antigen display platform for tumor vaccination via Plug-and-Display technology. Nat Commun Nat Res. 2021;12. https:\/\/doi.org\/10.1038\/s41467-021-22308-8.","DOI":"10.1038\/s41467-021-22308-8"},{"key":"2908_CR33","doi-asserted-by":"publisher","first-page":"109943","DOI":"10.1016\/j.fsi.2024.109943","volume":"154","author":"MP Escribano","year":"2024","unstructured":"Escribano MP, Balado M, Santos B, Toranzo AE, Lemos ML, Magari\u00f1os B. Outer membrane vesicles (OMVs) from tenacibaculum maritimum as a potential vaccine against fish tenacibaculosis. Fish Shellfish Immunol. 2024;154:109943. https:\/\/doi.org\/10.1016\/j.fsi.2024.109943.","journal-title":"Fish Shellfish Immunol"},{"key":"2908_CR34","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s13027-023-00480-4","volume":"18","author":"S Jalalifar","year":"2023","unstructured":"Jalalifar S, Morovati Khamsi H, Hosseini-Fard SR, Karampoor S, Bajelan B, Irajian G, et al. Emerging role of microbiota derived outer membrane vesicles to preventive, therapeutic and diagnostic proposes. Infect Agent Cancer. 2023;18:3. https:\/\/doi.org\/10.1186\/s13027-023-00480-4.","journal-title":"Infect Agent Cancer"},{"key":"2908_CR35","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.actbio.2019.04.033","volume":"91","author":"STT Schetters","year":"2019","unstructured":"Schetters STT, Jong WSP, Horrevorts SK, Kruijssen LJW, Engels S, Stolk D, et al. Outer membrane vesicles engineered to express membrane-bound antigen program dendritic cells for cross-presentation to CD8\u2009+\u2009T cells. Acta Biomater. 2019;91:248\u201357. https:\/\/doi.org\/10.1016\/j.actbio.2019.04.033.","journal-title":"Acta Biomater"},{"key":"2908_CR36","doi-asserted-by":"publisher","unstructured":"Zhu Z, Antenucci F, Villumsen KR, Bojesen AM. Bacterial outer membrane vesicles as a versatile tool in vaccine research and the fight against antimicrobial resistance. mBio. 2021;12. https:\/\/doi.org\/10.1128\/mBio.01707-21.","DOI":"10.1128\/mBio.01707-21"},{"key":"2908_CR37","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1016\/j.cell.2016.04.015","volume":"165","author":"SK Vanaja","year":"2016","unstructured":"Vanaja SK, Russo AJ, Behl B, Banerjee I, Yankova M, Deshmukh SD, et al. Bacterial outer membrane vesicles mediate cytosolic localization of LPS and Caspase-11 activation. Cell. 2016;165:1106\u201319. https:\/\/doi.org\/10.1016\/j.cell.2016.04.015.","journal-title":"Cell"},{"key":"2908_CR38","doi-asserted-by":"publisher","unstructured":"Ho NI, Huis in \u2019t Veld LGM, Raaijmakers TK, Adema GJ. Adjuvants enhancing cross-presentation by dendritic cells: the key to more effective vaccines? Front Immunol. 2018;9. https:\/\/doi.org\/10.3389\/fimmu.2018.02874","DOI":"10.3389\/fimmu.2018.02874"},{"key":"2908_CR39","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1083\/jcb.200508058","volume":"172","author":"MA Sanjuan","year":"2006","unstructured":"Sanjuan MA, Rao N, Lai K-TA, Gu Y, Sun S, Fuchs A, et al. CpG-induced tyrosine phosphorylation occurs via a TLR9-independent mechanism and is required for cytokine secretion. J Cell Biol. 2006;172:1057\u201368. https:\/\/doi.org\/10.1083\/jcb.200508058.","journal-title":"J Cell Biol"},{"key":"2908_CR40","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.3390\/life14121584","volume":"14","author":"B Velimirov","year":"2024","unstructured":"Velimirov B, Velimirov BA. Immune responses elicited by outer membrane vesicles of Gram-Negative bacteria: important players in vaccine development. Life. 2024;14:1584. https:\/\/doi.org\/10.3390\/life14121584.","journal-title":"Life"},{"key":"2908_CR41","doi-asserted-by":"publisher","unstructured":"Zhao T, Cai Y, Jiang Y, He X, Wei Y, Yu Y, et al. Vaccine adjuvants: mechanisms and platforms. Signal Transduct Target Ther. 2023. https:\/\/doi.org\/10.1038\/s41392-023-01557-7.","DOI":"10.1038\/s41392-023-01557-7"},{"key":"2908_CR42","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1007\/s41048-019-00095-6","volume":"5","author":"G Qing","year":"2019","unstructured":"Qing G, Gong N, Chen X, Chen J, Zhang H, Wang Y, et al. Natural and engineered bacterial outer membrane vesicles. Biophys Rep. 2019;5:184\u201398. https:\/\/doi.org\/10.1007\/s41048-019-00095-6.","journal-title":"Biophys Rep"},{"key":"2908_CR43","doi-asserted-by":"publisher","first-page":"2202","DOI":"10.1016\/j.vaccine.2005.01.058","volume":"23","author":"J HOLST","year":"2005","unstructured":"HOLST J, FEIRING B, NASS L, NORHEIM G, KRISTIANSEN P. The concept of ?tailor-made? protein-based, outer membrane vesicle vaccines against meningococcal disease. Vaccine. 2005;23:2202\u20135. https:\/\/doi.org\/10.1016\/j.vaccine.2005.01.058.","journal-title":"Vaccine"},{"key":"2908_CR44","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1128\/CVI.00102-07","volume":"14","author":"C Trotter","year":"2007","unstructured":"Trotter C, Findlow J, Balmer P, Holland A, Barchha R, Hamer N, et al. Seroprevalence of bactericidal and Anti-Outer membrane vesicle antibodies to Neisseria meningitidis group B in England. Clin Vaccine Immunol. 2007;14:863\u20138. https:\/\/doi.org\/10.1128\/CVI.00102-07.","journal-title":"Clin Vaccine Immunol"},{"key":"2908_CR45","doi-asserted-by":"publisher","unstructured":"Ochoa-Azze RF, Garc\u00eda-Im\u00eda L, V\u00e9rez-Bencomo V. Effectiveness of a serogroup B and C meningococcal vaccine developed in Cuba. MEDICC Rev. 2018; 20: 22-29. } https:\/\/doi.org\/10.37757\/mr2018.v20.n3.6}","DOI":"10.37757\/mr2018.v20.n3.6"},{"key":"2908_CR46","doi-asserted-by":"publisher","first-page":"5899","DOI":"10.1016\/j.vaccine.2008.08.062","volume":"26","author":"BJ Loring","year":"2008","unstructured":"Loring BJ, Turner N, Petousis-Harris H. MeNZB\u2122 vaccine and epidemic control: when do you stop vaccinating? Vaccine. 2008;26:5899\u2013904. https:\/\/doi.org\/10.1016\/j.vaccine.2008.08.062.","journal-title":"Vaccine"},{"key":"2908_CR47","doi-asserted-by":"publisher","first-page":"7100","DOI":"10.1016\/j.vaccine.2011.06.120","volume":"29","author":"R Arnold","year":"2011","unstructured":"Arnold R, Galloway Y, McNicholas A, O\u2019Hallahan J. Effectiveness of a vaccination programme for an epidemic of meningococcal B in new Zealand. Vaccine. 2011;29:7100\u20136. https:\/\/doi.org\/10.1016\/j.vaccine.2011.06.120.","journal-title":"Vaccine"},{"key":"2908_CR48","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.4161\/hv.24129","volume":"9","author":"J Holst","year":"2013","unstructured":"Holst J, Oster P, Arnold R, Tatley M, N\u00e6ss L, Aaberge I, et al. Vaccines against meningococcal serogroup B disease containing outer membrane vesicles (OMV): lessons from past programs and implications for the future. Hum Vaccin Immunother. 2013;9:1241\u201353. https:\/\/doi.org\/10.4161\/hv.24129.","journal-title":"Hum Vaccin Immunother"},{"key":"2908_CR49","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1016\/j.vaccine.2005.01.063","volume":"23","author":"P Oster","year":"2005","unstructured":"Oster P, Lennon D, Ohallahan J, Mulholland K, Reid S, Martin D. Menzb: a safe and highly Immunogenic tailor-made vaccine against the new Zealand serogroup B disease epidemic strain. Vaccine. 2005;23:2191\u20136. https:\/\/doi.org\/10.1016\/j.vaccine.2005.01.063.","journal-title":"Vaccine"},{"key":"2908_CR50","doi-asserted-by":"publisher","DOI":"10.18502\/ijm.v12i5.4602","author":"A Behrouzi","year":"2020","unstructured":"Behrouzi A, Arabi Mianroodi R, Afrough P, Ayadi A, Serajian A. Evaluation of immunological responses against outer membrane vesicles (OMV) of nontypeable haemophilus influenzae using MPLA -CpG adjuvant as a vaccine candidate. Iran J Microbiol. 2020. https:\/\/doi.org\/10.18502\/ijm.v12i5.4602.","journal-title":"Iran J Microbiol"},{"key":"2908_CR51","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.femsim.2004.03.005","volume":"41","author":"LO Fukasawa","year":"2004","unstructured":"Fukasawa LO, Dias WO, Schenkman RPF, Raw I, Tanizaki MM. Adjuvant can improve protection induced by OMV vaccine against Neisseria meningitidis serogroups B\/C in neonatal mice. FEMS Immunol Med Microbiol. 2004;41:205\u201310. https:\/\/doi.org\/10.1016\/j.femsim.2004.03.005.","journal-title":"FEMS Immunol Med Microbiol"},{"key":"2908_CR52","doi-asserted-by":"publisher","first-page":"110612","DOI":"10.1016\/j.intimp.2023.110612","volume":"122","author":"X Li","year":"2023","unstructured":"Li X, Huang Y, Sun J, Yu X, Xu X, Cui X, et al. Enhancing effect of Chitosan nanoparticles on the immune efficacy of Bordetella bronchiseptica outer membrane vesicles. Int Immunopharmacol. 2023;122:110612. https:\/\/doi.org\/10.1016\/j.intimp.2023.110612.","journal-title":"Int Immunopharmacol"},{"key":"2908_CR53","doi-asserted-by":"publisher","unstructured":"Tian H, Li B, Xu T, Yu H, Chen J, Yu H, et al. Outer membrane vesicles derived from Salmonella enterica serotype typhimurium can deliver Shigella flexneri 2a O-Polysaccharide antigen to prevent Shigella flexneri 2a infection in mice. Appl Environ Microbiol. 2021;87. https:\/\/doi.org\/10.1128\/AEM.00968-21.","DOI":"10.1128\/AEM.00968-21"},{"key":"2908_CR54","doi-asserted-by":"publisher","unstructured":"Micoli F, Rossi O, Conti V, Launay O, Scir\u00e9 AS, Aruta MG, et al. Antibodies elicited by the Shigella sonnei GMMA vaccine in adults trigger complement-mediated serum bactericidal activity: results from a phase 1 dose escalation trial followed by a booster extension. Front Immunol. 2021;12. https:\/\/doi.org\/10.3389\/fimmu.2021.671325.","DOI":"10.3389\/fimmu.2021.671325"},{"key":"2908_CR55","doi-asserted-by":"publisher","first-page":"328","DOI":"10.3390\/vaccines10020328","volume":"10","author":"F Micoli","year":"2022","unstructured":"Micoli F, Nakakana UN, Berlanda Scorza F. Towards a Four-Component GMMA-Based vaccine against Shigella. Vaccines (Basel). 2022;10:328. https:\/\/doi.org\/10.3390\/vaccines10020328.","journal-title":"Vaccines (Basel)"},{"key":"2908_CR56","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/s12951-025-03191-7","volume":"23","author":"R Feng","year":"2025","unstructured":"Feng R, Xue R-Y, Liu C, Li G-C, Deng Y, Jin Z, et al. RBD-displaying OMV nanovaccine boosts immunity against SARS-CoV-2. J Nanobiotechnol. 2025;23:97. https:\/\/doi.org\/10.1186\/s12951-025-03191-7.","journal-title":"J Nanobiotechnol"},{"key":"2908_CR57","doi-asserted-by":"publisher","unstructured":"Sun J, Lin X, He Y, Zhang B, Zhou N, Huang J. A bacterial outer membrane vesicle-based click vaccine elicits potent immune response against Staphylococcus aureus in mice. Front Immunol. 2023;14. https:\/\/doi.org\/10.3389\/fimmu.2023.1088501.","DOI":"10.3389\/fimmu.2023.1088501"},{"key":"2908_CR58","doi-asserted-by":"publisher","first-page":"105772","DOI":"10.1016\/j.isci.2022.105772","volume":"26","author":"J Wo","year":"2023","unstructured":"Wo J, Lv Z-Y, Sun J-N, Tang H, Qi N, Ye B-C. Engineering probiotic-derived outer membrane vesicles as functional vaccine carriers to enhance immunity against SARS-CoV-2. iScience. 2023;26:105772. https:\/\/doi.org\/10.1016\/j.isci.2022.105772.","journal-title":"iScience"},{"key":"2908_CR59","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1016\/j.ymthe.2017.01.010","volume":"25","author":"HC Watkins","year":"2017","unstructured":"Watkins HC, Rappazzo CG, Higgins JS, Sun X, Brock N, Chau A, et al. Safe Recombinant outer membrane vesicles that display M2e elicit heterologous influenza protection. Mol Ther. 2017;25:989\u20131002. https:\/\/doi.org\/10.1016\/j.ymthe.2017.01.010.","journal-title":"Mol Ther"},{"key":"2908_CR60","doi-asserted-by":"publisher","first-page":"46","DOI":"10.3390\/vaccines7020046","volume":"7","author":"MM Shehata","year":"2019","unstructured":"Shehata MM, Mostafa A, Teubner L, Mahmoud SH, Kandeil A, Elshesheny R, et al. Bacterial outer membrane vesicles (OMVs)-Based dual vaccine for influenza A H1N1 virus and MERS-CoV. Vaccines (Basel). 2019;7:46. https:\/\/doi.org\/10.3390\/vaccines7020046.","journal-title":"Vaccines (Basel)"},{"key":"2908_CR61","doi-asserted-by":"publisher","first-page":"767","DOI":"10.3390\/vaccines13070767","volume":"13","author":"A Zahid","year":"2025","unstructured":"Zahid A, Ismail H, Wilson JC, Grice ID. Bioengineering Outer-Membrane vesicles for vaccine development: Strategies, Advances, and perspectives. Vaccines (Basel). 2025;13:767. https:\/\/doi.org\/10.3390\/vaccines13070767.","journal-title":"Vaccines (Basel)"},{"key":"2908_CR62","doi-asserted-by":"publisher","unstructured":"Preto RM, dos Santos VCT, Lordelo MVS, Pereira GHF, Leite LC, de Gon\u00e7alves C. Optimization of methods for isolation and purification of outer membrane vesicles (OMVs) from neisseria lactamica. Appl Microbiol Biotechnol. 2025;109. https:\/\/doi.org\/10.1007\/s00253-025-13460-y.","DOI":"10.1007\/s00253-025-13460-y"},{"key":"2908_CR63","doi-asserted-by":"publisher","first-page":"135","DOI":"10.3390\/membranes14060135","volume":"14","author":"N Li","year":"2024","unstructured":"Li N, Wu M, Wang L, Tang M, Xin H, Deng K. Efficient isolation of outer membrane vesicles (OMVs) secreted by Gram-Negative bacteria via a novel gradient filtration method. Membr (Basel). 2024;14:135. https:\/\/doi.org\/10.3390\/membranes14060135.","journal-title":"Membr (Basel)"},{"key":"2908_CR64","doi-asserted-by":"publisher","first-page":"4416","DOI":"10.3390\/ijms21124416","volume":"21","author":"F Mancini","year":"2020","unstructured":"Mancini F, Rossi O, Necchi F, Micoli F. OMV vaccines and the role of TLR agonists in immune response. Int J Mol Sci. 2020;21:4416. https:\/\/doi.org\/10.3390\/ijms21124416.","journal-title":"Int J Mol Sci"},{"key":"2908_CR65","doi-asserted-by":"publisher","first-page":"24922","DOI":"10.1074\/jbc.M114.566570","volume":"289","author":"O Rossi","year":"2014","unstructured":"Rossi O, Pesce I, Giannelli C, Aprea S, Caboni M, Citiulo F, et al. Modulation of endotoxicity of Shigella generalized modules for membrane antigens (GMMA) by genetic lipid A modifications. J Biol Chem. 2014;289:24922\u201335. https:\/\/doi.org\/10.1074\/jbc.M114.566570.","journal-title":"J Biol Chem"},{"key":"2908_CR66","doi-asserted-by":"publisher","first-page":"552","DOI":"10.3390\/vaccines13060552","volume":"13","author":"L Lu","year":"2025","unstructured":"Lu L, Zhai L, Ou Q, Sang S, Cao C, Guan Y, et al. Engineered outer membrane vesicles for antigen delivery: exploratory study on adjuvant activity and systemic reactogenicity. Vaccines (Basel). 2025;13:552. https:\/\/doi.org\/10.3390\/vaccines13060552.","journal-title":"Vaccines (Basel)"},{"key":"2908_CR67","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1128\/IAI.66.4.1334-1341.1998","volume":"66","author":"B Haneberg","year":"1998","unstructured":"Haneberg B, Dalseg R, Wedege E, H\u00f8iby EA, Haugen IL, Oftung F, et al. Intranasal administration of a meningococcal outer membrane vesicle vaccine induces persistent local mucosal antibodies and serum antibodies with strong bactericidal activity in humans. Infect Immun. 1998;66:1334\u201341. https:\/\/doi.org\/10.1128\/IAI.66.4.1334-1341.1998.","journal-title":"Infect Immun"},{"key":"2908_CR68","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1128\/IAI.67.1.113-119.1999","volume":"67","author":"NB Saunders","year":"1999","unstructured":"Saunders NB, Shoemaker DR, Brandt BL, Moran EE, Larsen T, Zollinger WD. Immunogenicity of intranasally administered meningococcal native outer membrane vesicles in mice. Infect Immun. 1999;67:113\u20139. https:\/\/doi.org\/10.1128\/IAI.67.1.113-119.1999.","journal-title":"Infect Immun"},{"key":"2908_CR69","doi-asserted-by":"publisher","first-page":"5031","DOI":"10.1128\/IAI.73.8.5031-5038.2005","volume":"73","author":"DR Shoemaker","year":"2005","unstructured":"Shoemaker DR, Saunders NB, Brandt BL, Moran EE, LaClair AD, Zollinger WD. Intranasal delivery of group B meningococcal native outer membrane vesicle vaccine induces local mucosal and serum bactericidal antibody responses in rabbits. Infect Immun. 2005;73:5031\u20138. https:\/\/doi.org\/10.1128\/IAI.73.8.5031-5038.2005.","journal-title":"Infect Immun"},{"key":"2908_CR70","doi-asserted-by":"publisher","unstructured":"Rudi E, Gaillard E, Bottero D, Ebensen T, Guzman CA, Hozbor D. Mucosal vaccination with outer membrane vesicles derived from Bordetella pertussis reduces nasal bacterial colonization after experimental infection. Front Immunol. 2024;15. https:\/\/doi.org\/10.3389\/fimmu.2024.1506638.","DOI":"10.3389\/fimmu.2024.1506638"},{"key":"2908_CR71","doi-asserted-by":"publisher","first-page":"8222","DOI":"10.1016\/j.vaccine.2011.08.121","volume":"29","author":"AI Camacho","year":"2011","unstructured":"Camacho AI, de Souza J, S\u00e1nchez-G\u00f3mez S, Pardo-Ros M, Irache JM, Gamazo C. Mucosal immunization with Shigella flexneri outer membrane vesicles induced protection in mice. Vaccine. 2011;29:8222\u20139. https:\/\/doi.org\/10.1016\/j.vaccine.2011.08.121.","journal-title":"Vaccine"},{"key":"2908_CR72","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1038\/nri3837","volume":"15","author":"M Kaparakis-Liaskos","year":"2015","unstructured":"Kaparakis-Liaskos M, Ferrero RL. Immune modulation by bacterial outer membrane vesicles. Nat Rev Immunol. 2015;15:375\u201387. https:\/\/doi.org\/10.1038\/nri3837.","journal-title":"Nat Rev Immunol"},{"key":"2908_CR73","doi-asserted-by":"publisher","unstructured":"Fehres CM, van Uden NO, Yeremenko NG, Fernandez L, Franco Salinas G, van Duivenvoorde LM, et al. APRIL induces a novel subset of IgA\u2009+\u2009regulatory B cells that suppress inflammation via expression of IL-10 and PD-L1. Front Immunol. 2019;10. https:\/\/doi.org\/10.3389\/fimmu.2019.01368.","DOI":"10.3389\/fimmu.2019.01368"},{"key":"2908_CR74","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/nri2322","volume":"8","author":"A Cerutti","year":"2008","unstructured":"Cerutti A. The regulation of IgA class switching. Nat Rev Immunol. 2008;8:421\u201334. https:\/\/doi.org\/10.1038\/nri2322.","journal-title":"Nat Rev Immunol"},{"key":"2908_CR75","doi-asserted-by":"publisher","first-page":"3288","DOI":"10.1016\/j.vaccine.2013.05.020","volume":"31","author":"AI Camacho","year":"2013","unstructured":"Camacho AI, Irache JM, de Souza J, S\u00e1nchez-G\u00f3mez S, Gamazo C. Nanoparticle-based vaccine for mucosal protection against Shigella flexneri in mice. Vaccine. 2013;31:3288\u201394. https:\/\/doi.org\/10.1016\/j.vaccine.2013.05.020.","journal-title":"Vaccine"},{"key":"2908_CR76","doi-asserted-by":"publisher","first-page":"105100","DOI":"10.1016\/j.micinf.2023.105100","volume":"25","author":"U Bhaumik","year":"2023","unstructured":"Bhaumik U, Halder P, Howlader DR, Banerjee S, Maiti S, Dutta S, et al. A tetravalent Shigella outer membrane vesicles based candidate vaccine offered cross-protection against all the serogroups of Shigella in adult mice. Microbes Infect. 2023;25:105100. https:\/\/doi.org\/10.1016\/j.micinf.2023.105100.","journal-title":"Microbes Infect"},{"key":"2908_CR77","doi-asserted-by":"publisher","unstructured":"Price NL, Goyette-Desjardins G, Nothaft H, Valguarnera E, Szymanski CM, Segura M, et al. Glycoengineered outer membrane vesicles: a novel platform for bacterial vaccines. Sci Rep. 2016;6. https:\/\/doi.org\/10.1038\/srep24931.","DOI":"10.1038\/srep24931"},{"key":"2908_CR78","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s40259-023-00627-0","volume":"38","author":"F Micoli","year":"2024","unstructured":"Micoli F, Adamo R, Nakakana U. Outer membrane vesicle vaccine platforms. BioDrugs. 2024;38:47\u201359. https:\/\/doi.org\/10.1007\/s40259-023-00627-0.","journal-title":"BioDrugs"},{"key":"2908_CR79","doi-asserted-by":"publisher","unstructured":"Mancini F, Micoli F, Necchi F, Pizza M, Berlanda Scorza F, Rossi O. GMMA-Based vaccines: the known and the unknown. Front Immunol. 2021;12. https:\/\/doi.org\/10.3389\/fimmu.2021.715393.","DOI":"10.3389\/fimmu.2021.715393"},{"key":"2908_CR80","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s40580-024-00434-5","volume":"11","author":"MY Ho","year":"2024","unstructured":"Ho MY, Liu S, Xing B. Bacteria extracellular vesicle as nanopharmaceuticals for versatile biomedical potential. Nano Converg. 2024;11:28. https:\/\/doi.org\/10.1186\/s40580-024-00434-5.","journal-title":"Nano Converg"},{"key":"2908_CR81","doi-asserted-by":"publisher","unstructured":"Baker SM, Settles EW, Davitt C, Gellings P, Kikendall N, Hoffmann J, et al. Burkholderia Pseudomallei OMVs derived from infection mimicking conditions elicit similar protection to a live-attenuated vaccine. NPJ Vaccines Nat Res. 2021;6. https:\/\/doi.org\/10.1038\/s41541-021-00281-z.","DOI":"10.1038\/s41541-021-00281-z"},{"key":"2908_CR82","doi-asserted-by":"publisher","unstructured":"Jiang L, Driedonks TAP, Jong WSP, Dhakal S, H BvandenBvanS, Sitaras I, et al. A bacterial extracellular vesicle-based intranasal vaccine against SARS\u2010CoV\u20102 protects against disease and elicits neutralizing antibodies to wild\u2010type and delta variants. J Extracell Vesicles. 2022;11. https:\/\/doi.org\/10.1002\/jev2.12192.","DOI":"10.1002\/jev2.12192"},{"key":"2908_CR83","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1186\/s12951-023-01928-w","volume":"21","author":"K-S Park","year":"2023","unstructured":"Park K-S, Svennerholm K, Crescitelli R, L\u00e4sser C, Gribonika I, Andersson M, et al. Detoxified synthetic bacterial membrane vesicles as a vaccine platform against bacteria and SARS-CoV-2. J Nanobiotechnol. 2023;21:156. https:\/\/doi.org\/10.1186\/s12951-023-01928-w.","journal-title":"J Nanobiotechnol"},{"key":"2908_CR84","doi-asserted-by":"publisher","first-page":"3333","DOI":"10.1016\/j.cell.2023.06.020","volume":"186","author":"G Dolton","year":"2023","unstructured":"Dolton G, Rius C, Wall A, Szomolay B, Bianchi V, Galloway SAE, et al. Targeting of multiple tumor-associated antigens by individual T cell receptors during successful cancer immunotherapy. Cell. 2023;186:3333\u2013e334927. https:\/\/doi.org\/10.1016\/j.cell.2023.06.020.","journal-title":"Cell"},{"key":"2908_CR85","doi-asserted-by":"publisher","unstructured":"Thapa HB, M\u00fcller AM, Camilli A, Schild S. An intranasal vaccine based on outer membrane vesicles against SARS-CoV-2. Front Microbiol. 2021;12. https:\/\/doi.org\/10.3389\/fmicb.2021.752739.","DOI":"10.3389\/fmicb.2021.752739"},{"key":"2908_CR86","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202504101","author":"Y Gong","year":"2025","unstructured":"Gong Y, Hao W, Xu L, Yang Y, Dong Z, Pan P, et al. BCG-Derived outer membrane vesicles induce TLR2\u2010Dependent trained immunity to protect against polymicrobial sepsis. Adv Sci. 2025. https:\/\/doi.org\/10.1002\/advs.202504101.","journal-title":"Adv Sci"},{"key":"2908_CR87","doi-asserted-by":"publisher","unstructured":"Curley SM, Putnam D. Biological nanoparticles in vaccine development. Front Bioeng Biotechnol. 2022;10. https:\/\/doi.org\/10.3389\/fbioe.2022.867119.","DOI":"10.3389\/fbioe.2022.867119"},{"key":"2908_CR88","doi-asserted-by":"publisher","unstructured":"Pawar RR, Bardeskar P, Bhor VM. Opportunities and challenges in harnessing the immunomodulatory potential of bacterial extracellular vesicles as vaccine candidates. Discover Immun. 2025;2. https:\/\/doi.org\/10.1007\/s44368-025-00009-4.","DOI":"10.1007\/s44368-025-00009-4"},{"key":"2908_CR89","doi-asserted-by":"publisher","first-page":"12054","DOI":"10.3390\/ijms241512054","volume":"24","author":"F Tognetti","year":"2023","unstructured":"Tognetti F, Biagini M, Denis M, Berti F, Maione D, Stranges D. Evolution of vaccines formulation to tackle the challenge of Anti-Microbial resistant pathogens. Int J Mol Sci. 2023;24:12054. https:\/\/doi.org\/10.3390\/ijms241512054.","journal-title":"Int J Mol Sci"},{"key":"2908_CR90","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1080\/21645515.2020.1780092","volume":"17","author":"O Rossi","year":"2021","unstructured":"Rossi O, Citiulo F, Mancini F. Outer membrane vesicles: moving within the intricate labyrinth of assays that can predict risks of reactogenicity in humans. Hum Vaccin Immunother. 2021;17:601\u201313. https:\/\/doi.org\/10.1080\/21645515.2020.1780092.","journal-title":"Hum Vaccin Immunother"},{"key":"2908_CR91","doi-asserted-by":"publisher","unstructured":"Trzewikoswki de Lima G, Portilho AI, De Gaspari E. Cross-reactivity with Brazilian strains of Neisseria meningitidis B after immunization with outer membrane vesicles. Ther Adv Vaccines Immunother. 2019;7. https:\/\/doi.org\/10.1177\/2515135519894825.","DOI":"10.1177\/2515135519894825"},{"key":"2908_CR92","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.biotechadv.2017.05.003","volume":"35","author":"MJH Gerritzen","year":"2017","unstructured":"Gerritzen MJH, Martens DE, Wijffels RH, van der Pol L, Stork M. Bioengineering bacterial outer membrane vesicles as vaccine platform. Biotechnol Adv. 2017;35:565\u201374. https:\/\/doi.org\/10.1016\/j.biotechadv.2017.05.003.","journal-title":"Biotechnol Adv"},{"key":"2908_CR93","doi-asserted-by":"publisher","unstructured":"Zhou J, Zou S, Dai D, He L, Mou X, Zhao N, et al. Bacterial outer membrane vesicles: from physics to clinical. MedComm \u2013 Biomater Appl. 2025;4. https:\/\/doi.org\/10.1002\/mba2.70013.","DOI":"10.1002\/mba2.70013"},{"key":"2908_CR94","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1007\/s00253-024-13033-5","volume":"108","author":"EK Lei","year":"2024","unstructured":"Lei EK, Azmat A, Henry KA, Hussack G. Outer membrane vesicles as a platform for the discovery of antibodies to bacterial pathogens. Appl Microbiol Biotechnol. 2024;108:232. https:\/\/doi.org\/10.1007\/s00253-024-13033-5.","journal-title":"Appl Microbiol Biotechnol"},{"key":"2908_CR95","doi-asserted-by":"publisher","unstructured":"Zingl FG, Leitner DR, Thapa HB, Schild S. Outer membrane vesicles as versatile tools for therapeutic approaches. MicroLife. 2021;2. https:\/\/doi.org\/10.1093\/femsml\/uqab006.","DOI":"10.1093\/femsml\/uqab006"}],"container-title":["Microbial Cell Factories"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12934-025-02908-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12934-025-02908-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12934-025-02908-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T15:59:23Z","timestamp":1781625563000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12934-025-02908-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,30]]},"references-count":95,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2908"],"URL":"https:\/\/doi.org\/10.1186\/s12934-025-02908-5","relation":{},"ISSN":["1475-2859"],"issn-type":[{"value":"1475-2859","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,30]]},"assertion":[{"value":"30 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"31"}}